Abstract
Osteoporosis is an asymptomatic disease until a fracture occurs. Management includes primary prevention, early detection through targeted screening, and implementation of appropriate treatment and monitoring strategies. This article explores these issues in depth.
MeSH terms
-
Absorptiometry, Photon
-
Bone Density / drug effects
-
Calcitonin / therapeutic use
-
Diphosphonates / therapeutic use
-
Estrogen Replacement Therapy
-
Female
-
Fractures, Bone / prevention & control
-
Humans
-
Osteoporosis, Postmenopausal* / diagnosis
-
Osteoporosis, Postmenopausal* / drug therapy
-
Osteoporosis, Postmenopausal* / prevention & control
-
Raloxifene Hydrochloride / therapeutic use
-
Risk Factors
-
Selective Estrogen Receptor Modulators / therapeutic use
Substances
-
Diphosphonates
-
Selective Estrogen Receptor Modulators
-
Raloxifene Hydrochloride
-
Calcitonin